0.8975
-0.0198
(-2.16%)
At close: April 11 at 4:00:01 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
16,146
25,151
25,797
19,288
9,785
Operating Income
-16,146
-25,151
-25,797
-19,288
-9,785
Net Non Operating Interest Income Expense
2,882
1,551
821
-208
219
Other Income Expense
-2,633
-5,468
-6,084
5,028
-2,258
Pretax Income
-18,933
-29,068
-31,060
-14,468
-11,824
Net Income Common Stockholders
-18,933
-29,068
-31,060
-14,468
-11,824
Diluted NI Available to Com Stockholders
-18,933
-29,068
-31,060
-14,468
-11,824
Basic EPS
-0.98
-1.56
-1.69
-0.81
-0.90
Diluted EPS
-0.98
-1.56
-1.69
-0.81
-0.90
Basic Average Shares
19,541.0500
18,574.4840
18,394.8860
17,859.7130
13,169.2080
Diluted Average Shares
19,541.0500
18,574.4840
18,394.8860
17,859.7130
13,169.2080
Total Operating Income as Reported
-20,591
-29,395
-25,797
-19,288
-9,785
Total Expenses
16,146
25,151
25,797
19,288
9,785
Net Income from Continuing & Discontinued Operation
-18,933
-29,068
-31,060
-14,468
-11,824
Normalized Income
-13,264
-23,600
-24,976
-19,496
-9,566
Interest Income
--
1,565
835
120
225
Net Interest Income
2,882
1,551
821
-208
219
EBIT
-16,146
-25,151
-25,797
-19,288
-9,785
EBITDA
-15,437
-24,316
-25,020
-18,742
-9,499
Reconciled Depreciation
709
835
777
546
286
Net Income from Continuing Operation Net Minority Interest
-18,933
-29,068
-31,060
-14,468
-11,824
Total Unusual Items Excluding Goodwill
-5,669
-5,468
-6,084
5,028
-2,258
Total Unusual Items
-5,669
-5,468
-6,084
5,028
-2,258
Normalized EBITDA
-9,768
-18,848
-18,936
-23,770
-7,241
12/31/2020 - 7/31/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BONS.TA Bonus BioGroup Ltd.
16.50
+12.24%
CANF Can-Fite BioPharma Ltd.
1.5700
+12.30%
PLUR Pluri Inc.
3.8150
+2.01%
BLRX BioLineRx Ltd.
2.7500
+13.17%
ENTX Entera Bio Ltd.
1.6900
0.00%
NRSN NeuroSense Therapeutics Ltd.
1.0600
+8.16%
CGEN Compugen Ltd.
1.2600
+4.13%
ORMP Oramed Pharmaceuticals Inc.
2.1100
-0.94%
CLGN CollPlant Biotechnologies Ltd.
2.4377
-2.10%
PYPD PolyPid Ltd.
2.4800
-0.60%